scPharmaceuticals Inc. (SCPH) Tops Q1 EPS by 6c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.9 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• National CineMedia (NCMI) Misses Q2 EPS by 7c
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37